![Eric S. Hoffman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric S. Hoffman
Corporate Officer/Principal presso
FUSN PHAR
Profilo
Eric S.
Hoffman is currently the Senior Vice President-Business Development at Fusion Pharmaceuticals, Inc. He previously worked as the Director-Corporate & Business Development at Biogen, Inc. from 2006 to 2011, and as the Vice President-Corporate & Business Development at Idenix Pharmaceuticals LLC from 2011 to 2014.
He also served as a Research Analyst at JPMorgan Securities LLC.
From 2014 to 2018, he was the Chief Business Officer at Genocea Biosciences, Inc. and later became the Chief Business Officer at Vicarius Pharma AG.
Dr. Hoffman received his undergraduate degree from Trinity University and his doctorate from Yale University.
Posizioni attive di Eric S. Hoffman
| Società | Posizione | Inizio |
|---|---|---|
| FUSN PHAR | Corporate Officer/Principal | 21/09/2021 |
Precedenti posizioni note di Eric S. Hoffman
| Società | Posizione | Fine |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Corporate Officer/Principal | 01/09/2018 |
| IDENIX PHARMACEUTICALS INC | Contatto Relazioni con gli Investitori | 22/05/2013 |
| BIOGEN INC. | Public Communications Contact | 01/03/2010 |
Vicarius Pharma AG
 Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides research and development services for pharmaceutical, biotech and medical companies | Corporate Officer/Principal | - |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Formazione di Eric S. Hoffman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
62
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Trinity University
 Trinity University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Vicarius Pharma AG
Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides research and development services for pharmaceutical, biotech and medical companies | Commercial Services |
